Intelligence · Clinical Pipeline
Novo Nordisk A/S Pipeline
All ClinicalTrials.gov programs at Novo Nordisk A/S — phase, modality, and trial IDs.
- Programs
- 6
Quick answer
Novo Nordisk A/S has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane
Novo Nordisk A/S
Knee osteoarthritis
1 trial -
Sorvasta 20 mg filmsko obložene tablete, Sorvitimb 20 mg/10 mg filmsko obložene tablete, Sorvasta 10 mg filmsko obložene tablete, Sorvasta 40 mg filmsko obložene tablete, Sorvitimb 40 mg/10 mg filmsko obložene tablete
Novo Nordisk A/S
Hyperlipidaemia
1 trial -
Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 80 mg + 5 mg, tabletki, Telmisartan/Amlodipine/Hydrochlorothiazide, Tamloset 40 mg/5 mg tabletta, Tamloset 80 mg/10 mg tabletta, Telassmo 80 mg/10 mg tablete, Tamloset 80 mg/5 mg tabletta, Teldipin, 80 mg + 10 mg, tabletki, Telassmo 40 mg/5 mg tablete, Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 40 mg + 5 mg, tabletki, Telassmo 80 mg/5 mg tablete
Novo Nordisk A/S
Arterial hypertension
1 trial -
biphasic insulin aspart 30
Novo Nordisk A/S
Diabetes
2 trials -
insulin detemir
Novo Nordisk A/S
Diabetes
2 trials -
turoctocog alfa
Novo Nordisk A/S
Congenital Bleeding Disorder
2 trials
Frequently asked questions
How many pipeline programs does Novo Nordisk A/S have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs